Vasodilator Effects of Bis-Dihydropyridines Structurally Related to Nifedipine
Journal:
Medicinal Chemistry
Volume:
2
Page:
527-534
Author(s):
Raquel Gomez Pliego, Eduardo Ramirez-San Juan, Rene Miranda, Rafael Villalobos-Molina, Francisco Delgado, Roberto Osnaya and Jose Trujillo Ferrara
Vasopressin-Receptor Antagonists: A New Class of Agents for the Treatment of Hyponatremia
Journal:
Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume:
6
Page:
249-258
Author(s):
Beatriz R. Olson
Type 1 11 β-hydroxysteroid Dehydrogenase as Universal Drug Target in Metabolic Diseases?
Journal:
Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume:
6
Page:
259-269
Author(s):
Udo Oppermann
A Review of the Treatment of Psoriasis with Infliximab
Journal:
Reviews on Recent Clinical Trials
Volume:
1
Page:
201-205
Author(s):
Theodora Vamvouris and Suhail Hadi
Reversal of Resistance to Oxazaphosphorines
Journal:
Current Cancer Drug Targets
Volume:
6
Page:
385-407
Author(s):
Jing Zhang, Quan Tian, Yi-Zhun Zhu, An-Long Xu and Shu-Feng Zhou
Metformin Beyond Diabetes: New Life for an Old Drug
Journal:
Current Diabetes Reviews
Volume:
2
Page:
307-315
Author(s):
Carlo M. Rotella, Matteo Monami and Edoardo Mannucci
Multidrug Transporters as Drug Targets
Journal:
Current Drug Targets
Volume:
7
Page:
911-921
Author(s):
X-J. Liang and A. Aszalos
Tachykinins and the Cardiovascular System
Journal:
Current Drug Targets
Volume:
7
Page:
1031-1042
Author(s):
David A. Walsh and Daniel F. McWilliams
Tachykinins and their Receptors in Human Malignancies
Journal:
Current Drug Targets
Volume:
7
Page:
1043-1052
Author(s):
Carla Palma
Barker and Brenner: A Basis for Hypertension?
Journal:
Current Hypertension Reviews
Volume:
2
Page:
179-185
Author(s):
Karen M. Moritz and John F. Bertram